View Profile
Find all started threads
Private Message
View Blog Entries
Federal court hearings continued Tuesday on a lawsuit that could transform biotechnology in the United States by eliminating gene patents.
The case hinges around the claims of Utah-based Myriad Genetics on BRCA1 and BRCA2, a pair of genes closely linked to breast and ovarian cancer. Myriad “owns” the genes, and says*its patents make it possible to [...]
Link To Original Article
Reply With Quote
Bookmarks